Cancer Discov. 2014 Feb;4(2):136-7. doi: 10.1158/2159-8290.CD-NB2013-176. Epub 2013 Dec 12.
The Chinese Academy of Sciences' Shanghai Institute of Materia Medica will collaborate with Crown Biosciences to build a collection of about 4,000 patient-derived xenograft models that will aid cancer drug discovery and development.
中国科学院上海药物研究所将与冠科生物合作,建立一个约 4000 例患者来源的异种移植模型的集合,以帮助癌症药物的发现和开发。